EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | chr1:204534494-204536271:+ | ENST00000463049.4 | ENSG00000198625.11 | MDM4 | ncRNA_intronic | AluY,AluSz,AluSg4,L1MC4a,AluJb | chr1:204534494-204536271:+.alignment |
chr1:204534494-204536271:+ | ENST00000470908.4 | ENSG00000198625.11 | MDM4 | ncRNA_intronic | AluY,AluSz,AluSg4,L1MC4a,AluJb | chr1:204534494-204536271:+.alignment |
chr1:204534494-204536271:+ | ENST00000471783.1 | ENSG00000198625.11 | MDM4 | ncRNA_intronic | AluY,AluSz,AluSg4,L1MC4a,AluJb | chr1:204534494-204536271:+.alignment |
chr1:204550350-204553184:+ | ENST00000463049.4 | ENSG00000198625.11 | MDM4 | ncRNA_exonic | AluJo,AluJb,AluJr4,(T)n,MER30,AluSq2,AluSg,Charlie2a,AluSp | chr1:204550350-204553184:+.alignment |
chr1:204555235-204557725:+ | ENST00000367182.6 | ENSG00000198625.11 | MDM4 | UTR3 | AluY,MIRc,AluJb,LTR8,AluSx | chr1:204555235-204557725:+.alignment |
chr1:204555235-204557725:+ | ENST00000367183.6 | ENSG00000198625.11 | MDM4 | UTR3 | AluY,MIRc,AluJb,LTR8,AluSx | chr1:204555235-204557725:+.alignment |
chr1:204555235-204557725:+ | ENST00000391947.5 | ENSG00000198625.11 | MDM4 | UTR3 | AluY,MIRc,AluJb,LTR8,AluSx | chr1:204555235-204557725:+.alignment |
chr1:204555235-204557725:+ | ENST00000454264.5 | ENSG00000198625.11 | MDM4 | UTR3 | AluY,MIRc,AluJb,LTR8,AluSx | chr1:204555235-204557725:+.alignment |
chr1:204555235-204557725:+ | ENST00000612738.3 | ENSG00000198625.11 | MDM4 | UTR3 | AluY,MIRc,AluJb,LTR8,AluSx | chr1:204555235-204557725:+.alignment |
chr1:204555235-204557725:+ | ENST00000614459.3 | ENSG00000198625.11 | MDM4 | UTR3 | AluY,MIRc,AluJb,LTR8,AluSx | chr1:204555235-204557725:+.alignment |
chr1:204555235-204557725:+ | ENST00000616250.3 | ENSG00000198625.11 | MDM4 | UTR3 | AluY,MIRc,AluJb,LTR8,AluSx | chr1:204555235-204557725:+.alignment |
ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
chr1:204555235-204557725:+ | ACC | EER | T_cells_CD4_memory_activated | 3.1836e-02 | -0.2481 |  |
ENSG00000198625.11,MDM4 | ACC | EAG | T_cells_CD4_memory_activated | 2.6409e-02 | -0.2564 |  |
chr1:204550350-204553184:+ | BLCA | EER | Macrophages_M2 | 3.5651e-02 | 0.1398 |  |
chr1:204555235-204557725:+ | BLCA | EER | Macrophages_M1 | 1.0510e-07 | 0.2624 |  |
ENSG00000198625.11,MDM4 | BLCA | EAG | Macrophages_M1 | 2.9758e-08 | 0.2724 |  |
chr1:204534494-204536271:+ | BRCA | EER | Dendritic_cells_activated | 4.2219e-02 | 0.1827 |  |
chr1:204550350-204553184:+ | BRCA | EER | T_cells_regulatory_(Tregs) | 1.2109e-03 | 0.1047 | .chr1_204550350-204553184_+.png) |
chr1:204555235-204557725:+ | BRCA | EER | T_cells_follicular_helper | 8.5334e-04 | -0.1012 |  |
ENSG00000198625.11,MDM4 | BRCA | EAG | B_cells_naive | 1.4998e-03 | -0.0964 |  |
chr1:204555235-204557725:+ | CESC | EER | Mast_cells_resting | 8.4942e-03 | -0.1525 |  |
ENSG00000198625.11,MDM4 | CESC | EAG | B_cells_naive | 1.0628e-02 | -0.1471 |  |
chr1:204555235-204557725:+ | CHOL | EER | T_cells_gamma_delta | 7.6696e-03 | -0.4432 |  |
ENSG00000198625.11,MDM4 | CHOL | EAG | T_cells_gamma_delta | 1.2274e-02 | -0.4188 |  |
chr1:204555235-204557725:+ | COAD | EER | Neutrophils | 6.2443e-04 | 0.2073 |  |
chr1:204550350-204553184:+ | DLBC | EER | Monocytes | 2.1094e-02 | 0.3831 |  |
chr1:204555235-204557725:+ | DLBC | EER | Mast_cells_resting | 1.1349e-03 | 0.4648 |  |
ENSG00000198625.11,MDM4 | DLBC | EAG | Mast_cells_resting | 1.2339e-03 | 0.4572 |  |
chr1:204534494-204536271:+ | ESCA | EER | T_cells_gamma_delta | 1.5410e-04 | 0.3732 |  |
chr1:204550350-204553184:+ | ESCA | EER | NK_cells_activated | 1.5899e-02 | 0.1898 |  |
chr1:204555235-204557725:+ | ESCA | EER | Macrophages_M2 | 8.1838e-05 | 0.3063 |  |
ENSG00000198625.11,MDM4 | ESCA | EAG | NK_cells_resting | 3.1384e-03 | -0.2314 |  |
chr1:204550350-204553184:+ | GBM | EER | T_cells_CD4_memory_activated | 7.3489e-03 | 0.2477 |  |
chr1:204555235-204557725:+ | GBM | EER | Neutrophils | 6.9972e-04 | 0.2605 |  |
ENSG00000198625.11,MDM4 | GBM | EAG | Neutrophils | 7.8340e-04 | 0.2582 |  |
chr1:204555235-204557725:+ | HNSC | EER | T_cells_follicular_helper | 1.4785e-02 | -0.1179 |  |
ENSG00000198625.11,MDM4 | HNSC | EAG | T_cells_follicular_helper | 6.6060e-03 | -0.1292 |  |
chr1:204555235-204557725:+ | KICH | EER | Eosinophils | 1.8839e-02 | 0.2929 |  |
ENSG00000198625.11,MDM4 | KICH | EAG | Eosinophils | 2.1220e-02 | 0.2876 |  |
ENSG00000198625.11,MDM4 | KIRC | EAG | Plasma_cells | 1.9727e-02 | 0.1200 |  |
chr1:204550350-204553184:+ | KIRP | EER | Macrophages_M1 | 2.6972e-02 | -0.1765 |  |
chr1:204555235-204557725:+ | KIRP | EER | T_cells_CD4_memory_activated | 1.3917e-03 | 0.1918 |  |
ENSG00000198625.11,MDM4 | KIRP | EAG | T_cells_CD4_memory_activated | 3.8814e-03 | 0.1733 |  |
chr1:204534494-204536271:+ | LAML | EER | Monocytes | 3.5122e-02 | 0.1728 |  |
chr1:204550350-204553184:+ | LAML | EER | Neutrophils | 2.7924e-02 | -0.1999 |  |
chr1:204555235-204557725:+ | LAML | EER | T_cells_CD4_memory_resting | 9.1060e-03 | 0.2123 |  |
ENSG00000198625.11,MDM4 | LAML | EAG | T_cells_CD4_memory_resting | 1.4105e-02 | 0.2001 |  |
chr1:204555235-204557725:+ | LGG | EER | T_cells_follicular_helper | 6.9483e-04 | -0.1472 |  |
ENSG00000198625.11,MDM4 | LGG | EAG | T_cells_follicular_helper | 7.2344e-04 | -0.1467 |  |
chr1:204550350-204553184:+ | LIHC | EER | T_cells_CD4_memory_activated | 3.8935e-02 | -0.1694 |  |
chr1:204555235-204557725:+ | LIHC | EER | T_cells_CD4_memory_activated | 5.3249e-03 | 0.1495 |  |
ENSG00000198625.11,MDM4 | LIHC | EAG | T_cells_CD4_memory_activated | 1.8431e-02 | 0.1256 |  |
chr1:204534494-204536271:+ | LUAD | EER | T_cells_regulatory_(Tregs) | 2.4748e-02 | 0.4026 | .chr1_204534494-204536271_+.png) |
chr1:204550350-204553184:+ | LUAD | EER | T_cells_CD8 | 4.0413e-04 | 0.1767 |  |
chr1:204555235-204557725:+ | LUAD | EER | T_cells_CD4_naive | 6.8974e-06 | 0.1998 |  |
ENSG00000198625.11,MDM4 | LUAD | EAG | Macrophages_M2 | 4.0467e-04 | 0.1567 |  |
chr1:204550350-204553184:+ | LUSC | EER | Plasma_cells | 2.1232e-02 | -0.1186 |  |
chr1:204555235-204557725:+ | LUSC | EER | T_cells_CD4_memory_activated | 8.7756e-03 | 0.1183 |  |
ENSG00000198625.11,MDM4 | LUSC | EAG | T_cells_CD4_memory_activated | 3.0032e-03 | 0.1337 |  |
chr1:204550350-204553184:+ | MESO | EER | B_cells_memory | 8.5023e-04 | 0.5186 |  |
chr1:204555235-204557725:+ | MESO | EER | T_cells_CD8 | 3.9945e-02 | 0.2288 |  |
ENSG00000198625.11,MDM4 | MESO | EAG | T_cells_CD8 | 2.4930e-02 | 0.2491 |  |
chr1:204534494-204536271:+ | OV | EER | NK_cells_activated | 1.0643e-04 | 0.5351 |  |
chr1:204550350-204553184:+ | OV | EER | T_cells_CD4_memory_activated | 1.5098e-04 | 0.2290 |  |
chr1:204555235-204557725:+ | OV | EER | T_cells_CD8 | 1.8657e-05 | 0.2510 |  |
ENSG00000198625.11,MDM4 | OV | EAG | T_cells_CD8 | 1.0474e-04 | 0.2262 |  |
chr1:204550350-204553184:+ | PCPG | EER | T_cells_gamma_delta | 2.6607e-02 | 0.2595 |  |
chr1:204555235-204557725:+ | PCPG | EER | Mast_cells_resting | 4.4702e-03 | -0.2098 |  |
ENSG00000198625.11,MDM4 | PCPG | EAG | Mast_cells_resting | 6.9457e-03 | -0.1995 |  |
chr1:204550350-204553184:+ | PRAD | EER | Mast_cells_resting | 5.9759e-04 | 0.1858 |  |
chr1:204555235-204557725:+ | PRAD | EER | Mast_cells_activated | 3.0463e-02 | -0.0973 |  |
ENSG00000198625.11,MDM4 | PRAD | EAG | Mast_cells_activated | 1.5363e-02 | -0.1088 |  |
chr1:204550350-204553184:+ | READ | EER | Plasma_cells | 1.5069e-02 | 0.3727 |  |
ENSG00000198625.11,MDM4 | READ | EAG | B_cells_naive | 4.0926e-02 | -0.2124 |  |
chr1:204550350-204553184:+ | SARC | EER | T_cells_CD4_memory_resting | 1.1112e-02 | -0.2370 |  |
chr1:204555235-204557725:+ | SARC | EER | Macrophages_M2 | 7.0721e-04 | 0.2145 |  |
ENSG00000198625.11,MDM4 | SARC | EAG | Macrophages_M2 | 3.4521e-04 | 0.2259 |  |
chr1:204550350-204553184:+ | SKCM | EER | T_cells_gamma_delta | 5.1075e-03 | 0.1513 |  |
chr1:204555235-204557725:+ | SKCM | EER | T_cells_CD4_memory_activated | 1.3767e-02 | -0.1155 |  |
ENSG00000198625.11,MDM4 | SKCM | EAG | T_cells_CD4_memory_activated | 2.2511e-02 | -0.1067 |  |
chr1:204550350-204553184:+ | STAD | EER | Eosinophils | 1.3200e-02 | -0.1318 |  |
chr1:204555235-204557725:+ | STAD | EER | Eosinophils | 5.4964e-05 | 0.2136 |  |
ENSG00000198625.11,MDM4 | STAD | EAG | T_cells_CD8 | 3.0242e-02 | 0.1133 |  |
chr1:204550350-204553184:+ | TGCT | EER | Mast_cells_activated | 2.3169e-03 | 0.2826 |  |
chr1:204555235-204557725:+ | TGCT | EER | T_cells_CD4_memory_activated | 4.6706e-03 | 0.2254 |  |
ENSG00000198625.11,MDM4 | TGCT | EAG | T_cells_CD4_memory_activated | 3.5946e-03 | 0.2318 |  |
chr1:204550350-204553184:+ | THCA | EER | T_cells_CD4_memory_resting | 1.3195e-02 | -0.1291 |  |
chr1:204555235-204557725:+ | THCA | EER | T_cells_CD4_memory_resting | 5.8899e-03 | 0.1228 |  |
ENSG00000198625.11,MDM4 | THCA | EAG | Dendritic_cells_activated | 2.3359e-02 | 0.1010 |  |
chr1:204555235-204557725:+ | THYM | EER | Macrophages_M0 | 4.7135e-03 | 0.2596 |  |
ENSG00000198625.11,MDM4 | THYM | EAG | Mast_cells_resting | 3.5810e-05 | 0.3708 |  |
chr1:204550350-204553184:+ | UCS | EER | T_cells_CD4_memory_activated | 5.6445e-03 | 0.4151 |  |
chr1:204555235-204557725:+ | UCS | EER | T_cells_follicular_helper | 4.9768e-02 | -0.2635 |  |
ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
ENSG00000198625.11,MDM4 | ACC | GSVA_HALLMARK_BILE_ACID_METABOLISM | EAG | 3.0630e-03 | 0.3375 |  |
chr1:204555235-204557725:+ | ACC | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 6.3015e-03 | 0.3127 |  |
chr1:204555235-204557725:+ | BLCA | GSVA_HALLMARK_INFLAMMATORY_RESPONSE | EER | 8.2284e-12 | 0.3334 |  |
ENSG00000198625.11,MDM4 | BLCA | GSVA_HALLMARK_INFLAMMATORY_RESPONSE | EAG | 2.3249e-13 | 0.3551 |  |
chr1:204550350-204553184:+ | BLCA | GSVA_HALLMARK_GLYCOLYSIS | EER | 2.8445e-06 | 0.3056 |  |
chr1:204555235-204557725:+ | BRCA | GSVA_HALLMARK_ANDROGEN_RESPONSE | EER | 3.9374e-11 | 0.1991 |  |
chr1:204534494-204536271:+ | BRCA | GSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSE | EER | 6.6777e-05 | 0.3502 |  |
chr1:204550350-204553184:+ | BRCA | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 2.3604e-18 | 0.2778 |  |
ENSG00000198625.11,MDM4 | BRCA | GSVA_HALLMARK_GLYCOLYSIS | EAG | 6.6836e-14 | 0.2250 |  |
chr1:204555235-204557725:+ | CESC | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 1.9514e-04 | 0.2145 |  |
chr1:204550350-204553184:+ | CESC | GSVA_HALLMARK_COAGULATION | EER | 2.2183e-04 | 0.2854 |  |
ENSG00000198625.11,MDM4 | CESC | GSVA_HALLMARK_COAGULATION | EAG | 8.7831e-05 | 0.2241 |  |
chr1:204550350-204553184:+ | CHOL | GSVA_HALLMARK_UV_RESPONSE_UP | EER | 1.2439e-02 | 0.4830 |  |
ENSG00000198625.11,MDM4 | CHOL | GSVA_HALLMARK_APICAL_SURFACE | EAG | 3.7490e-02 | 0.3531 |  |
chr1:204555235-204557725:+ | CHOL | GSVA_HALLMARK_PROTEIN_SECRETION | EER | 9.9429e-03 | 0.4300 |  |
chr1:204550350-204553184:+ | COAD | GSVA_HALLMARK_PROTEIN_SECRETION | EER | 1.0907e-02 | 0.2087 |  |
ENSG00000198625.11,MDM4 | COAD | GSVA_HALLMARK_ANDROGEN_RESPONSE | EAG | 1.2926e-03 | 0.1945 |  |
chr1:204555235-204557725:+ | COAD | GSVA_HALLMARK_ANDROGEN_RESPONSE | EER | 5.5928e-03 | 0.1685 |  |
chr1:204555235-204557725:+ | DLBC | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EER | 8.1550e-03 | -0.3855 |  |
chr1:204550350-204553184:+ | DLBC | GSVA_HALLMARK_TGF_BETA_SIGNALING | EER | 4.5355e-02 | -0.3357 |  |
ENSG00000198625.11,MDM4 | DLBC | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EAG | 1.9402e-03 | -0.4406 |  |
chr1:204550350-204553184:+ | ESCA | GSVA_HALLMARK_DNA_REPAIR | EER | 9.6502e-03 | 0.2034 |  |
chr1:204555235-204557725:+ | ESCA | GSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | EER | 5.4003e-04 | 0.2705 |  |
ENSG00000198625.11,MDM4 | ESCA | GSVA_HALLMARK_MYOGENESIS | EAG | 2.7675e-02 | 0.1736 |  |
chr1:204534494-204536271:+ | ESCA | GSVA_HALLMARK_APICAL_JUNCTION | EER | 1.3168e-05 | 0.4246 |  |
ENSG00000198625.11,MDM4 | GBM | GSVA_HALLMARK_BILE_ACID_METABOLISM | EAG | 1.3820e-03 | 0.2463 |  |
chr1:204555235-204557725:+ | GBM | GSVA_HALLMARK_BILE_ACID_METABOLISM | EER | 4.5354e-03 | 0.2193 |  |
chr1:204550350-204553184:+ | GBM | GSVA_HALLMARK_MTORC1_SIGNALING | EER | 6.2193e-03 | 0.2526 |  |
chr1:204555235-204557725:+ | HNSC | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 8.3230e-08 | 0.2558 |  |
ENSG00000198625.11,MDM4 | HNSC | GSVA_HALLMARK_HYPOXIA | EAG | 4.5508e-07 | 0.2374 |  |
chr1:204550350-204553184:+ | HNSC | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 8.1693e-04 | -0.2314 |  |
ENSG00000198625.11,MDM4 | KIRC | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EAG | 5.9793e-10 | 0.3119 |  |
chr1:204555235-204557725:+ | KIRC | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 1.2157e-10 | 0.3245 |  |
chr1:204550350-204553184:+ | KIRC | GSVA_HALLMARK_COAGULATION | EER | 4.1700e-06 | 0.2764 |  |
chr1:204550350-204553184:+ | KIRP | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 5.1949e-03 | 0.2220 |  |
chr1:204555235-204557725:+ | KIRP | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 9.4414e-07 | 0.2906 |  |
ENSG00000198625.11,MDM4 | KIRP | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 6.4081e-07 | 0.2943 |  |
chr1:204555235-204557725:+ | LAML | GSVA_HALLMARK_G2M_CHECKPOINT | EER | 2.2182e-05 | -0.3389 |  |
chr1:204534494-204536271:+ | LAML | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 4.4607e-02 | 0.1648 |  |
ENSG00000198625.11,MDM4 | LAML | GSVA_HALLMARK_G2M_CHECKPOINT | EAG | 7.4006e-04 | -0.2725 |  |
chr1:204550350-204553184:+ | LAML | GSVA_HALLMARK_PEROXISOME | EER | 1.1761e-03 | 0.2916 |  |
ENSG00000198625.11,MDM4 | LGG | GSVA_HALLMARK_ESTROGEN_RESPONSE_EARLY | EAG | 2.3277e-17 | 0.3575 |  |
chr1:204555235-204557725:+ | LGG | GSVA_HALLMARK_UV_RESPONSE_DN | EER | 1.9253e-13 | 0.3127 |  |
chr1:204550350-204553184:+ | LGG | GSVA_HALLMARK_FATTY_ACID_METABOLISM | EER | 3.2902e-06 | 0.2506 |  |
chr1:204555235-204557725:+ | LIHC | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 6.0222e-08 | 0.2862 |  |
chr1:204550350-204553184:+ | LIHC | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 1.0411e-04 | 0.3126 |  |
ENSG00000198625.11,MDM4 | LIHC | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 6.2557e-08 | 0.2835 |  |
chr1:204555235-204557725:+ | LUAD | GSVA_HALLMARK_APOPTOSIS | EER | 1.1054e-12 | 0.3114 |  |
chr1:204534494-204536271:+ | LUAD | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 9.8300e-04 | 0.5627 |  |
chr1:204550350-204553184:+ | LUAD | GSVA_HALLMARK_COMPLEMENT | EER | 2.5302e-06 | 0.2336 |  |
ENSG00000198625.11,MDM4 | LUAD | GSVA_HALLMARK_APOPTOSIS | EAG | 7.2021e-15 | 0.3366 |  |
ENSG00000198625.11,MDM4 | LUSC | GSVA_HALLMARK_APOPTOSIS | EAG | 5.6741e-08 | 0.2420 |  |
chr1:204555235-204557725:+ | LUSC | GSVA_HALLMARK_GLYCOLYSIS | EER | 8.0339e-09 | 0.2568 |  |
chr1:204550350-204553184:+ | LUSC | GSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKB | EER | 1.4126e-03 | 0.1638 |  |
ENSG00000198625.11,MDM4 | MESO | GSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | EAG | 9.2037e-04 | 0.3613 |  |
chr1:204555235-204557725:+ | MESO | GSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | EER | 6.6348e-04 | 0.3704 |  |
chr1:204550350-204553184:+ | MESO | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EER | 2.7444e-02 | 0.3577 |  |
ENSG00000198625.11,MDM4 | OV | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 1.9264e-09 | 0.3438 |  |
chr1:204534494-204536271:+ | OV | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EER | 6.5768e-03 | 0.3910 |  |
chr1:204550350-204553184:+ | OV | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 7.5760e-07 | 0.2962 |  |
chr1:204555235-204557725:+ | OV | GSVA_HALLMARK_FATTY_ACID_METABOLISM | EER | 4.8070e-07 | 0.2934 |  |
chr1:204555235-204557725:+ | PAAD | GSVA_HALLMARK_MTORC1_SIGNALING | EER | 2.4627e-04 | 0.2738 |  |
ENSG00000198625.11,MDM4 | PAAD | GSVA_HALLMARK_MTORC1_SIGNALING | EAG | 9.3750e-05 | 0.2902 |  |
chr1:204550350-204553184:+ | PCPG | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EER | 5.5765e-03 | 0.3213 |  |
ENSG00000198625.11,MDM4 | PCPG | GSVA_HALLMARK_PROTEIN_SECRETION | EAG | 4.8750e-04 | 0.2560 |  |
chr1:204555235-204557725:+ | PCPG | GSVA_HALLMARK_PROTEIN_SECRETION | EER | 2.2117e-03 | 0.2255 |  |
chr1:204550350-204553184:+ | PRAD | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 5.9646e-05 | -0.2166 |  |
ENSG00000198625.11,MDM4 | PRAD | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 1.4646e-07 | 0.2334 |  |
chr1:204555235-204557725:+ | PRAD | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 7.4122e-07 | 0.2203 |  |
chr1:204550350-204553184:+ | READ | GSVA_HALLMARK_COMPLEMENT | EER | 4.0619e-02 | 0.3173 |  |
ENSG00000198625.11,MDM4 | READ | GSVA_HALLMARK_P53_PATHWAY | EAG | 2.4478e-02 | 0.2332 |  |
chr1:204555235-204557725:+ | READ | GSVA_HALLMARK_P53_PATHWAY | EER | 2.4118e-02 | 0.2350 |  |
ENSG00000198625.11,MDM4 | SARC | GSVA_HALLMARK_GLYCOLYSIS | EAG | 4.2593e-06 | 0.2878 |  |
chr1:204550350-204553184:+ | SARC | GSVA_HALLMARK_COAGULATION | EER | 8.3287e-04 | 0.3087 |  |
chr1:204555235-204557725:+ | SARC | GSVA_HALLMARK_GLYCOLYSIS | EER | 8.0853e-06 | 0.2802 |  |
chr1:204550350-204553184:+ | SKCM | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 1.0867e-08 | 0.3034 |  |
chr1:204555235-204557725:+ | SKCM | GSVA_HALLMARK_APICAL_JUNCTION | EER | 9.8594e-11 | 0.2975 |  |
ENSG00000198625.11,MDM4 | SKCM | GSVA_HALLMARK_APICAL_JUNCTION | EAG | 3.7935e-10 | 0.2875 |  |
chr1:204534494-204536271:+ | STAD | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 3.8683e-06 | 0.3410 |  |
chr1:204555235-204557725:+ | STAD | GSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE | EER | 2.2599e-06 | 0.2493 |  |
chr1:204550350-204553184:+ | STAD | GSVA_HALLMARK_MYC_TARGETS_V2 | EER | 3.1493e-03 | 0.1567 |  |
ENSG00000198625.11,MDM4 | STAD | GSVA_HALLMARK_UV_RESPONSE_UP | EAG | 1.2807e-05 | 0.2259 |  |
chr1:204555235-204557725:+ | TGCT | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EER | 4.9720e-03 | 0.2238 |  |
ENSG00000198625.11,MDM4 | TGCT | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EAG | 4.5043e-03 | 0.2263 |  |
chr1:204550350-204553184:+ | TGCT | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 5.4888e-03 | 0.2585 |  |
chr1:204550350-204553184:+ | THCA | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 3.3979e-04 | 0.1858 |  |
ENSG00000198625.11,MDM4 | THCA | GSVA_HALLMARK_ESTROGEN_RESPONSE_EARLY | EAG | 2.8819e-05 | 0.1852 |  |
chr1:204555235-204557725:+ | THCA | GSVA_HALLMARK_ESTROGEN_RESPONSE_EARLY | EER | 2.8028e-07 | 0.2268 |  |
chr1:204555235-204557725:+ | THYM | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 1.2741e-04 | 0.3469 |  |
chr1:204550350-204553184:+ | THYM | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EER | 1.2838e-03 | 0.3145 |  |
ENSG00000198625.11,MDM4 | THYM | GSVA_HALLMARK_G2M_CHECKPOINT | EAG | 1.5202e-04 | -0.3418 |  |
chr1:204555235-204557725:+ | UCEC | GSVA_HALLMARK_ADIPOGENESIS | EER | 1.8982e-02 | 0.1814 |  |
chr1:204550350-204553184:+ | UCEC | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 1.0192e-03 | 0.2939 |  |
ENSG00000198625.11,MDM4 | UCEC | GSVA_HALLMARK_MITOTIC_SPINDLE | EAG | 3.4633e-04 | -0.2682 |  |
ENSG00000198625.11,MDM4 | UCS | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 7.5565e-03 | 0.3533 |  |
chr1:204555235-204557725:+ | UCS | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 6.8659e-03 | 0.3573 |  |
chr1:204550350-204553184:+ | UCS | GSVA_HALLMARK_DNA_REPAIR | EER | 7.8961e-03 | 0.3998 |  |
ENSG00000198625.11,MDM4 | UVM | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 1.6545e-05 | 0.5067 |  |
chr1:204555235-204557725:+ | UVM | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 2.4142e-05 | 0.4982 |  |
ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
ENSG00000198625.11,MDM4 | ACC | Etoposide | EAG | 1.2717e-04 | 0.4282 |  |
chr1:204555235-204557725:+ | ACC | Etoposide | EER | 7.0846e-05 | 0.4423 |  |
chr1:204555235-204557725:+ | BLCA | CMK | EER | 2.8499e-16 | -0.3940 |  |
ENSG00000198625.11,MDM4 | BLCA | CMK | EAG | 2.6246e-17 | -0.4055 |  |
chr1:204550350-204553184:+ | BLCA | CMK | EER | 3.8827e-05 | -0.2701 |  |
chr1:204534494-204536271:+ | BRCA | ABT.263 | EER | 3.0547e-04 | 0.3190 |  |
chr1:204550350-204553184:+ | BRCA | A.770041 | EER | 3.6813e-17 | -0.2684 |  |
ENSG00000198625.11,MDM4 | BRCA | ATRA | EAG | 4.7450e-05 | 0.1234 |  |
chr1:204555235-204557725:+ | BRCA | KIN001.135 | EER | 7.2444e-05 | -0.1203 |  |
ENSG00000198625.11,MDM4 | CESC | CCT007093 | EAG | 1.8079e-09 | 0.3378 |  |
chr1:204550350-204553184:+ | CESC | Dasatinib | EER | 1.1011e-03 | -0.2549 |  |
chr1:204555235-204557725:+ | CESC | CCT007093 | EER | 4.8691e-06 | 0.2617 |  |
chr1:204550350-204553184:+ | CHOL | A.770041 | EER | 1.5724e-04 | -0.6746 |  |
ENSG00000198625.11,MDM4 | CHOL | CHIR.99021 | EAG | 1.6792e-02 | -0.4016 |  |
chr1:204555235-204557725:+ | CHOL | AMG.706 | EER | 8.9576e-03 | 0.4353 |  |
chr1:204555235-204557725:+ | COAD | BMS.708163 | EER | 2.1844e-07 | -0.3096 |  |
ENSG00000198625.11,MDM4 | COAD | BMS.708163 | EAG | 7.9093e-04 | -0.2027 |  |
chr1:204550350-204553184:+ | DLBC | EHT.1864 | EER | 4.1820e-02 | 0.3410 |  |
chr1:204555235-204557725:+ | DLBC | BX.795 | EER | 1.6163e-02 | 0.3528 |  |
ENSG00000198625.11,MDM4 | DLBC | BX.795 | EAG | 8.7743e-03 | 0.3781 |  |
chr1:204555235-204557725:+ | ESCA | GSK269962A | EER | 3.9315e-04 | -0.2769 |  |
chr1:204534494-204536271:+ | ESCA | Bexarotene | EER | 7.0167e-04 | -0.3366 |  |
ENSG00000198625.11,MDM4 | GBM | BI.2536 | EAG | 7.1387e-04 | 0.2601 |  |
chr1:204555235-204557725:+ | GBM | BI.2536 | EER | 1.2985e-03 | 0.2476 |  |
chr1:204550350-204553184:+ | GBM | Docetaxel | EER | 2.4538e-03 | -0.2787 |  |
chr1:204550350-204553184:+ | HNSC | BI.D1870 | EER | 4.3582e-08 | -0.3701 |  |
ENSG00000198625.11,MDM4 | HNSC | Erlotinib | EAG | 1.6398e-11 | -0.3135 |  |
chr1:204555235-204557725:+ | HNSC | IPA.3 | EER | 1.0904e-07 | 0.2536 |  |
ENSG00000198625.11,MDM4 | KICH | AS601245 | EAG | 1.5878e-02 | 0.3004 |  |
chr1:204555235-204557725:+ | KICH | AS601245 | EER | 1.4228e-02 | 0.3051 |  |
ENSG00000198625.11,MDM4 | KIRC | A.770041 | EAG | 5.8456e-11 | -0.3289 |  |
chr1:204555235-204557725:+ | KIRC | A.770041 | EER | 5.8826e-06 | -0.2315 |  |
chr1:204550350-204553184:+ | KIRC | BAY.61.3606 | EER | 8.3816e-09 | 0.3422 |  |
chr1:204555235-204557725:+ | KIRP | IPA.3 | EER | 2.0350e-06 | 0.2819 |  |
ENSG00000198625.11,MDM4 | KIRP | IPA.3 | EAG | 4.4094e-07 | 0.2984 |  |
chr1:204550350-204553184:+ | KIRP | Embelin | EER | 1.9290e-04 | 0.2933 |  |
ENSG00000198625.11,MDM4 | LAML | LFM.A13 | EAG | 3.5255e-03 | -0.2368 |  |
chr1:204534494-204536271:+ | LAML | BIRB.0796 | EER | 2.4356e-02 | 0.1844 |  |
chr1:204555235-204557725:+ | LAML | AS601245 | EER | 7.7708e-03 | -0.2166 |  |
chr1:204550350-204553184:+ | LAML | FTI.277 | EER | 1.4908e-02 | -0.2209 |  |
chr1:204555235-204557725:+ | LGG | JNK.9L | EER | 6.4069e-14 | 0.3186 |  |
ENSG00000198625.11,MDM4 | LGG | Cytarabine | EAG | 2.7867e-13 | 0.3107 |  |
chr1:204550350-204553184:+ | LGG | GNF.2 | EER | 1.1149e-07 | -0.2846 |  |
chr1:204550350-204553184:+ | LIHC | JNK.Inhibitor.VIII | EER | 1.3657e-03 | 0.2600 |  |
chr1:204555235-204557725:+ | LIHC | AZD8055 | EER | 6.2601e-05 | -0.2135 |  |
ENSG00000198625.11,MDM4 | LIHC | CCT007093 | EAG | 4.5735e-07 | 0.2649 |  |
chr1:204555235-204557725:+ | LUAD | Gemcitabine | EER | 7.7097e-08 | -0.2377 |  |
chr1:204534494-204536271:+ | LUAD | BMS.708163 | EER | 1.2983e-02 | 0.4412 |  |
chr1:204550350-204553184:+ | LUAD | BMS.509744 | EER | 1.2635e-04 | -0.1912 |  |
ENSG00000198625.11,MDM4 | LUAD | Gemcitabine | EAG | 2.8742e-08 | -0.2436 |  |
chr1:204555235-204557725:+ | LUSC | BMS.509744 | EER | 2.4480e-07 | -0.2306 |  |
ENSG00000198625.11,MDM4 | LUSC | BMS.509744 | EAG | 2.4061e-07 | -0.2305 |  |
chr1:204550350-204553184:+ | LUSC | CI.1040 | EER | 9.8542e-04 | -0.1690 |  |
chr1:204555235-204557725:+ | MESO | BIRB.0796 | EER | 9.1945e-04 | 0.3613 |  |
ENSG00000198625.11,MDM4 | MESO | BIRB.0796 | EAG | 1.0324e-03 | 0.3580 |  |
chr1:204550350-204553184:+ | MESO | A.443654 | EER | 1.0887e-02 | -0.4085 |  |
ENSG00000198625.11,MDM4 | OV | MG.132 | EAG | 8.7936e-09 | -0.3308 |  |
chr1:204534494-204536271:+ | OV | CEP.701 | EER | 1.0226e-03 | -0.4639 |  |
chr1:204555235-204557725:+ | OV | MG.132 | EER | 2.9511e-06 | -0.2737 |  |
chr1:204550350-204553184:+ | OV | A.770041 | EER | 3.2538e-09 | -0.3509 |  |
chr1:204555235-204557725:+ | PAAD | AUY922 | EER | 2.3058e-02 | -0.1717 |  |
ENSG00000198625.11,MDM4 | PAAD | AUY922 | EAG | 2.8485e-02 | -0.1652 |  |
chr1:204550350-204553184:+ | PCPG | AUY922 | EER | 1.8646e-02 | -0.2748 |  |
chr1:204555235-204557725:+ | PCPG | GSK.650394 | EER | 5.8261e-05 | 0.2934 |  |
ENSG00000198625.11,MDM4 | PCPG | Cyclopamine | EAG | 5.1170e-05 | 0.2955 |  |
ENSG00000198625.11,MDM4 | PRAD | BMS.509744 | EAG | 1.5226e-05 | -0.1929 |  |
chr1:204550350-204553184:+ | PRAD | BMS.536924 | EER | 7.6686e-05 | -0.2143 |  |
chr1:204555235-204557725:+ | PRAD | BMS.754807 | EER | 4.5923e-08 | -0.2426 |  |
chr1:204550350-204553184:+ | SARC | BMS.536924 | EER | 1.8108e-06 | -0.4299 |  |
chr1:204555235-204557725:+ | SARC | Dasatinib | EER | 1.1113e-05 | -0.2761 |  |
ENSG00000198625.11,MDM4 | SARC | AG.014699 | EAG | 1.0401e-07 | 0.3306 |  |
chr1:204550350-204553184:+ | SKCM | GNF.2 | EER | 3.0156e-04 | -0.1946 |  |
chr1:204555235-204557725:+ | SKCM | Bexarotene | EER | 2.4973e-16 | -0.3718 |  |
ENSG00000198625.11,MDM4 | SKCM | Bexarotene | EAG | 9.5288e-13 | -0.3256 |  |
chr1:204534494-204536271:+ | STAD | BI.2536 | EER | 3.9122e-03 | 0.2170 |  |
chr1:204555235-204557725:+ | STAD | AZ628 | EER | 1.8239e-06 | -0.2515 |  |
chr1:204550350-204553184:+ | STAD | GW843682X | EER | 3.7673e-05 | -0.2175 |  |
ENSG00000198625.11,MDM4 | STAD | AZ628 | EAG | 1.5877e-05 | -0.2235 |  |
chr1:204555235-204557725:+ | TGCT | AZD6244 | EER | 3.4291e-04 | -0.2831 |  |
ENSG00000198625.11,MDM4 | TGCT | AZD6244 | EAG | 1.3845e-04 | -0.3004 |  |
chr1:204550350-204553184:+ | TGCT | Camptothecin | EER | 2.0054e-02 | -0.2176 |  |
chr1:204550350-204553184:+ | THCA | GSK269962A | EER | 8.9359e-06 | -0.2292 |  |
ENSG00000198625.11,MDM4 | THCA | CI.1040 | EAG | 6.8277e-06 | -0.1989 |  |
chr1:204555235-204557725:+ | THCA | AMG.706 | EER | 3.0426e-04 | 0.1606 |  |
chr1:204555235-204557725:+ | THYM | AZD6244 | EER | 6.8700e-10 | -0.5317 |  |
chr1:204550350-204553184:+ | THYM | CGP.082996 | EER | 1.1708e-02 | 0.2487 |  |
ENSG00000198625.11,MDM4 | THYM | ABT.263 | EAG | 7.6577e-05 | 0.3559 |  |
chr1:204555235-204557725:+ | UCEC | AZD6482 | EER | 1.2733e-05 | 0.3307 |  |
chr1:204550350-204553184:+ | UCEC | Erlotinib | EER | 2.6862e-06 | -0.4103 |  |
ENSG00000198625.11,MDM4 | UCEC | Dasatinib | EAG | 5.5460e-09 | -0.4262 |  |
ENSG00000198625.11,MDM4 | UCS | AZ628 | EAG | 4.8976e-03 | -0.3708 |  |
chr1:204555235-204557725:+ | UCS | AZ628 | EER | 3.3950e-03 | -0.3850 |  |
chr1:204550350-204553184:+ | UCS | ABT.888 | EER | 1.3409e-02 | -0.3743 |  |
ENSG00000198625.11,MDM4 | UVM | Bexarotene | EAG | 1.1130e-06 | -0.5619 |  |
chr1:204555235-204557725:+ | UVM | Bexarotene | EER | 3.0139e-06 | -0.5427 |  |